Age-related qualitative shift in emotional behaviour: Paradoxical findings after re-exposure of rats in the elevated-plus maze

被引:35
作者
Bessa, JM
Oliveira, M
Cerqueira, JJ
Almeida, OFX
Sousa, N
机构
[1] Univ Minho, Life & Hlth Sci Res Inst ICVS, Neurosci Grp, P-4710057 Braga, Portugal
[2] Max Planck Inst Psychiat, Neuroadaptat Grp, Munich, Germany
关键词
aging; anxiety; open arm avoidance; one trial tolerance; risk assessment; elevated-plus maze; rat;
D O I
10.1016/j.bbr.2005.03.005
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
Several variables, including age, are known to influence anxiety. Previous exposure to the elevated-plus maze (EPM) is known to modify emotional behaviour as retesting in the EPM at a standard age of 3 months increases open-arm avoidance and attenuates the effects of anxiolytic drugs. This study analysed whether similar results are obtained when older animals are subjected to these experimental paradigms. Overall, increasing age was associated with more signs of anxiety. Additionally, we observed a paradoxical behaviour pattern in aged-subjects that were re-exposed to the EPM, with mid-aged and old rats failing to display open arm avoidance (OAA) in the second trial; this qualitative shift in emotional behaviour was not associated with decreased locomotion. An examination of how age influences responsiveness to anxiolytic drugs, with or without previous maze experience, was also conducted. Midazolam (0.5 and 1 mg/kg) proved anxiolytic in maize-naive young animals; in marked contrast, in older animals midazolam at 1 mg/kg resulted in sedation but not anxiolyis. One trial tolerance to midazolam was evident in animals of both ages that were subjected to a second EPM trial; the latter phenomenon was apparently accentuated in older animals as they do not show open arm avoidance upon re-exposure to the EPM. These data suggest that the age-associated 'resistance' to anxiolytic drugs might be related to a qualitative shift in emotional behaviour. (C) 2005 Elsevier B.V. All rights reserved.
引用
收藏
页码:135 / 142
页数:8
相关论文
共 44 条
[11]   Functions of cannabinoid receptors in the hippocampus [J].
Davies, SN ;
Pertwee, RG ;
Riedel, G .
NEUROPHARMACOLOGY, 2002, 42 (08) :993-1007
[12]   ONE-TRIAL TOLERANCE TO THE EFFECTS OF CHLORDIAZEPOXIDE ON THE ELEVATED PLUS-MAZE MAY BE DUE TO LOCOMOTOR HABITUATION, NOT REPEATED DRUG EXPOSURE [J].
DAWSON, GR ;
CRAWFORD, SP ;
STANHOPE, KJ ;
IVERSEN, SD ;
TRICKLEBANK, MD .
PSYCHOPHARMACOLOGY, 1994, 113 (3-4) :570-572
[13]   USE OF THE ELEVATED PLUS-MAZE IN THE SEARCH FOR NOVEL ANXIOLYTIC AGENTS [J].
DAWSON, GR ;
TRICKLEBANK, MD .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1995, 16 (02) :33-36
[14]   Activation of corticotropin-releasing factor in the limbic system during cannabinoid withdrawal [J].
deFonseca, FR ;
Carrera, MRA ;
Navarro, M ;
Koob, GF ;
Weiss, F .
SCIENCE, 1997, 276 (5321) :2050-2054
[15]   The influence of open arm ledges and maze experience in the elevated plus-maze [J].
Fernandes, C ;
File, SE .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1996, 54 (01) :31-40
[16]   TRIAL 2 IN THE ELEVATED PLUS-MAZE - A DIFFERENT FORM OF FEAR [J].
FILE, SE ;
ZANGROSSI, H ;
VIANA, M ;
GRAEFF, FG .
PSYCHOPHARMACOLOGY, 1993, 111 (04) :491-494
[17]   CHARACTERIZATION OF THE PHENOMENON OF ONE-TRIAL TOLERANCE TO THE ANXIOLYTIC EFFECT OF CHLORDIAZEPOXIDE IN THE ELEVATED PLUS-MAZE [J].
FILE, SE ;
MABBUTT, PS ;
HITCHCOTT, PK .
PSYCHOPHARMACOLOGY, 1990, 102 (01) :98-101
[18]   One-trial tolerance to the effects of chlordiazepoxide in the elevated plus-maze is not due to acquisition of a phobic avoidance of open arms during initial exposure [J].
Frussa-Filho, R ;
Ribeiro, RD .
LIFE SCIENCES, 2002, 71 (05) :519-525
[19]   Risk assessment behaviour: Evaluation of utility in the study of 5-HT-related drugs in the rat elevated plus-maze test [J].
Griebel, G ;
Rodgers, RJ ;
Perrault, G ;
Sanger, DJ .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1997, 57 (04) :817-827
[20]  
GRIEBEL G, 1993, BEHAV P, V29, P129